San Diego, CA -- (SBWIRE) -- 08/25/2015 -- An investigation for investors, who currently hold shares of Merge Healthcare Inc. (NASDAQ:MRGE), was announced concerning whether the takeover of Merge Healthcare Inc. by IBM for $7.13 per share is unfair to NASDAQ:MRGE stockholders. On August 6, 2015, IBM and Merge Healthcare Inc. (NASDAQ:MRGE) announced the signing of a merger agreement pursuant to which IBM will acquire Merge Healthcare Inc.

Investors who purchased shares of Merge Healthcare Inc. (NASDAQ:MRGE) and currently hold any of those NASDAQ:MRGE shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call 858-779-1554.

The investigation by a law firm concerns whether certain officers and directors of Merge Healthcare Inc. breached their fiduciary duties owed to NASDAQ:MRGE investors in connection with the proposed acquisition.

Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash, for a total transaction value of $1 billion.

However, the investigation concerns whether the offer is unfair to NASDAQ:MRGE stockholders. More specifically, the investigation concerns whether the Merge Healthcare Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Shares of Merge Healthcare Inc. (NASDAQ:MRGE) closed on August 24, 2015, at $7.08 per share.

Those who are current investors in Merge Healthcare Inc. (NASDAQ:MRGE) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com